Search

everythinglearnresearchcommunity

for

Search:↓

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Autophagy is essential for proper skin cell development and function.

Satoyoshi syndrome is likely an autoimmune disease.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Autoimmune markers may help diagnose and manage PCOS.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Microneedling can effectively treat hair loss and works well with other treatments, but more research is needed.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

TGF-β signaling is essential for new hair growth after wounds.

More precise, personalized therapies are needed for autoimmune diseases.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Ruxolitinib cream may help treat severe hair loss in children.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.